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Abstract 
Immunology is the emerging research area which deals with the study of immune system in any living organism. It is modeled 
through various computational and mathematical models to deal with the problem facing while to boost the immune system of any 
organism or to fight with the infectious disease at the very initial stage. Such models are very important for a better understanding 
of the complex behavior of pathways inside the cells.  The signaling pathways between the cells are complex and difficult to 
visualize in the immune system of human beings. So, it’s important to study about the function of these cells separately. T-cells 
and B-cells are the important part of immune system and both have their own receptors and their different signaling pathways by 
which they deal with any antigens.  In this paper we discuss about B-cell receptor (BCR) and its different signaling pathways 
downstream of the BCR. We designed a Petri-net model of the process of gathering antigens through B-cells independent of T-cell 
and the effect of that in immune system of the organism. We will also discuss the contribution of BCR in the selection of the 
precursor tumor cell in CLL (chronic lymphocytic leukemia). 
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1. Introduction 
 
We are surrounded all the time the millions of bacteria or viruses and if it was not a well develop immune system then 
we would be infected by certain number of infections from time to time. The word immunology comes from the study 
that how an individual recovered from any infectious diseases and could be protected from the disease. The Latin term 
immunis, meaning “exempt” ,which means the process of protection from any infectious disease. So, it’s important to 
build a healthy immune system so to be protected by several antigens. The Immune system of a human being is highly 
complex and a major challenge for scientists in the field of medicine, and pharmacology. The immune system is 
expanded in the whole body which involves certain different cells, tissues and organs [1, 2]. The two type of immune 
system is Innate or Acquired. The innate system recognizes the set of patterns that the antigens follow. On the other 
hand the acquired system recognizes several different types of antigens. The T and B-cells are the part of this acquired 
immune system. In particular B-cells participate in HUMORAL immunity and it is the only cells that synthesize 
immunoglobulin [3]. Immunoglobulin is the antigens that are secreted from the cells.  The main components of this 
system are lymphatic system, lymphoid tissues, lymph nodes, thymus and spleen [4]. The main purpose is to study 
that how the immune system secretes antibodies that allow B-cells to bind with a specific antigen, to initiate the 
antibody response. Further BCR signaling constitutes different downstream pathways which act differently in different 
diseases [5]. The mature B-lymphocytes has an important role in identifying the proper precursor in tumor cell. CLL 
is the most common leukemia in the western countries. This CLL don’t have strong responses to immune therapies so 
the advances have been made in chemotherapies and how to select the proper antibodies to prevent it on the initial 
stage [6]. So to get clear information it is important to model the system with a discrete mathematical modeling. 
 
2. Motivation and Plan 
 
Considering the importance of immune system it is better to study the function step by step. Biological networks these 
days are modeled with several computational and mathematical models such as differential equation, process algebra 
[7] and certain other field of science. Petri net graph are also one of the mathematical model which in these days are 
most in use to model several biological system [8, 9]. Petri net act as a tool which provides graphical and mathematical 
view of a system.  Due to its dynamic discrete behavior it can show the interrelationship between the states involving 
in any system. Several high level Petri net tools [10,11] are also available to model the concurrent and synchronized 
system which makes Petri net a novel model in several field of science.  In this paper we plan to model the B-cell 
receptor signaling pathways and their behavior in different deficiencies. We have also inspired to model the effect of 
BCR in CLL as it is taking one of the downstream pathways from the four pathways of BCR [12].   
 
3. Biological background 
 
3.1  B-cell receptor 
 
B-cell, B-lymphocytes are a part of white blood cell originated and matured in the bone marrow. It is an important part of the 
Immune System. B-cell has a type of receptors on its cell surface which binds with the antigens and then it proliferates. B-cell 
activation can be T-cell dependent or T-cell independent. 95% of antigens are T-dependent but those which are T-independent 
are acting differently. In T-dependent antigens the immune system responses much stronger than T-independent as in that case 
memory cells are generated, induction of isotype switching occurs, and affinity maturation generated. The parts of the B-cell 
receptor (BCR) are shown in the Figure 1, which consists of antigen binding site, different regions and chains [13,14]. 
 
                                      
                                                                     Figure 1: B-cell receptor (BCR)  
 
3.2 BCR  Signaling pathways 
 
In this paper we specifically designed the model for B-cell activation independent to T-cell. B-cell generates 
plasma cell which secretes antibodies which protect the human body against the infections by binding the 
viruses and microbial toxins [15].  The magnitude and duration of BCR signaling are affected by the MAPK 
pathways, the P13K pathways, NFAT pathways, NF- 𝛼𝛽 pathways, and internalization of the BCR [15]. In 
general, B cells are often activated by antigen-presenting cells that capture antigens and display them on their 
cell surface. Activation of B cells by such membrane-associated antigens requires BCR-induced cytoskeletal 
reorganization [16]. Figure: 2, shows the different downstream pathway followed in BCR signaling and also 
the enzymes responsible for the functioning of BCR in immune system 
 
                                                          
                     
                                                               Figure 2: B-cell Signalling pathways 
 
4. Methods 
    
4.1 Petri net 
Petri net is a special type of directed graph that can be used to study the dynamics of the modeled system. Petri net is 5-tuple set, 
consisting of a finite set of places represented as a circle, a finite set of transitions represented as a rectangle, positive incidence 
function that denotes the number of arc from any transition to place, negative incidence function that denotes the number of arc 
from any place to transition and the initial marking which represents the number of tokens on each places. Tokens are represented 
as black dots.  Mathematically Petri net is represented as:  
                                                                        𝑃𝑁 = (𝑃, 𝑇, 𝐼+, 𝐼−, µ
0
)                     
Any transition fires at the given marking if and only if the outgoing arcs from all the places is less than and equal to the present 
marking of that place. After firing the tokens are moved from the input places and deposited on the output places accordingly. It 
changes the marking and a new marking obtained for the places associated with that transition. All these marking collectively form 
a reachability graph of that Petri net. This graph shows the reachable state from other states, which helps to obtained the relation 
between one state to another state. Several properties of Petri net is very beneficiary to draws some useful results of the modeled 
system [17, 18, 19]. 
 
4.2 Properties of Petri net 
 
State machine: The Petri net in which each transition is strictly having one input and one output place.  
Marked graph: A Petri net is a marked graph if each place is input for exactly one transition and also output for exactly one 
transition. 
Bounded: A Petri net is bounded if the number of tokens on each place never be infinite, i.e., number of tokens remains finite. 
Free choice net: It is an ordinary Petri net such that every arc from a place is either a unique outgoing or a unique incoming arc 
to a transition. 
Extended free choice net:  Any Petri net is extended free choice net if and only if for all transition there exists an another 
transition from the same net whose pre places set have at least one common place. 
Liveness and Reachability: A Petri net is live if every transition of the net is live. Any transition is live in a marking µ if for each 
marking µ’ there exists a marking sequence where that transition is enabled in marking µ. If any of the transition is not live then 
that transition is known as dead transition and hence the Petri net is deadlock. 
Safeness: A Petri net is safe if the number of tokens on any place never exceeds one. 
Simple net: A Petri net is a simple net if each transition has at most one input place which is shared with another transition. 
All these properties of Petri net are very helpful in studying any system [20, 21, 22]. 
Some basic structures which is not allowed to be a marked graph, free choice net and simple net are shown in Figure 3.  
 
                                                     
                                                            Figure 3:  Forbidden structures  
5. Modeling and Analysis  
 
While modeling any system we first analyze the key elements, events and their relationships within the pathways. These 
steps help us to model the places and transition accordingly. Modeling the B-cell receptor signaling pathways we 
represents the molecular activities or stable compounds as places while the metabolic enzymes or responses (binding, 
proliferation etc) taken as transitions and the relationship between the activities with the corresponding enzymes are 
shown by the arcs.  The tokens on the places shows the availability of the corresponding compound and flow of tokens 
means the use of one compound to combine with some enzymes to produce another compound. The Petri net model of 
B-cell receptor signalling pathways is shown in Figure 3. 
 
5.1 Petri net model of B-cell receptor signaling pathways  
 
 
                                  
 
                                              Figure 4: Petri net modeling of B-cell signaling pathway 
  
 
Places Description  Transitions Description 
p0 Antigens t0 Binding with IGL and IGH in BCR 
p1 BCR t1 Tyrosine kinase activity to generate 
MAPKKK 
p2 CD79A+CD79B t2 Tyrosine kinase activity to generate 
P13K 
p3 SFK+SYK t3 Tyrosine kinase activity and Ca+2 
mobilization 
p4 MAKKK t4 Tyrosine kinase activity to generate 
BTK 
p5 P13K t5 Phosphorylation 
p6 Calcineurin t6 Activation of IGF1 
p7 BTK t7 Dephosphorylation and entry of 
NFATc protein 
p8 Activation of MAPK pathway t8 Proliferation and differentiation 
p9 Activation of P13K pathway   
p10 Activation of NFAT pathway   
p11 Activation of NF-αβ pathway   
 
5.2   Analysis of the model 
 
To check the validity of model shown in Figure 4, we have taken one token in p0 which means the availability of antigens inside 
the body and is ready to bind with b-cell receptor in the presence of IGH and IGR through the transition t0. Firing of t0 will implies 
the token shift to p1 which is BCR which is responsible for the further steps to recover from the antigens effect. Now as the places 
p2 and p3 represents the availability of (CD79A + CD79B)   and  (SFK +SYK) enzymes which are already present in our body. So, 
we have assumed one token on both the places. In next step the transitions t1, t2, t3, t4 are enabled but only one will  
fire depending on the antigen associated with BCR.  These four transitions will decide which pathways will follow to reduce the 
adverse effect of the antigens. It all depends on tyrosine kinase activity that which pathway will lead to cure from the particular 
disorder. If t1 will fire that means token shifts to place p4 which is generation of MAPKKK protein. If t2 will fire then the token 
shifts to p5 which means the formation of P13K protein. Similarly if  t3 will fire token shifts to place p6 which means the generation 
of calmodulin which is a well known calcium sensor protein which further activates to become  phosphotase Calcineurin. If t4 will 
fire then token shifts to p7which means the generation of BTK protein [23,24,25]. 
 
5.3 Validation 
 
The model is validated from the online software PIPE (Platform Independent Petri Net Editor v4.3.0) [26]. 
 
              
 
                                                         Figure 5: Property analysis with PIPE 
 
From Figure 5 we can analyze that it is not a  state machine as t1, t2, t3, t4 are the transitions having more than one input. As we 
know any enzyme present in the body is not responsible for a single proliferation rather it can involved in so many reactions. It is 
not a free choice and simple net but can be extended to follow both properties by modeling the enzymes differently with its specific 
properties. The system is bounded and safe means accumulation of any enzymes  is not occurring. While studying about the 
different states in this model it is important to know about the path by which one state is reachable from another one . the Figure 
6, shows the coverability graph of the model S6, S7, S8, S9 are the tangible states and rest are the vanishing states. 
 
                                                     
                                                                     Figure 6: Coverability graph  
 
In this coverability graph it has been validated that the four downstream pathways of BCR is independent from each other and 
originated from the same node i.e., B-cell receptor.  
 
 
6. Role of BCR in CLL 
 
Chronic Leukemia is the cancer of leukocytes in which lots of partially developed white blood cells are present in blood which 
interfere the development and function of healthy blood cells and platelets.  Two types of chronic leukemia can occur in the body 
either CML (chronic myeloid leukemia) [27] which affects granulocytes   or CLL (chronic lymphocytic leukemia) [28] which 
affects lymphocytes especially b-cells. These premature cells which should die early are present in the blood and slow down the 
function of the mature cells and weaken the immune system of the body. These immature cells when come in the contact of BCR 
interfere with the cells BTK which stops the CLL cells to mature fully and interfering with other tyrosine kinases made them die 
slower before they divide.  These premature cells contains proteins CD5, CD23 and CD19 on their surfaces which comes in the 
contact of B-cell receptors.  BTK and P13K are the critical enzymes present in BCR which is responsible for the activation of AKT, 
NF-kβ pathways which promotes survival and proliferation of CLL cells [29]. 
 
7. Final summary and scope  
 
As the researches in Immunology are becoming trends in the field of science and medicines so it is highly in need to model the 
system in different ways to study about the function and parts of the system properly. In this paper we have discussed the function 
of b-cell receptor when defending from the antigens coming from outside and attacking the human body. The main step is the one 
when it is being decided that which path should follow to cure the particular infection. The four pathway MAPK pathway, P13K 
pathways, NFAT pathways, and NF-αβ pathway works differently in different diseases.   
For example the (P13K –AKT-mTOR) pathway  helps to cure the breast cancer in early steps with the help of Phosphoinositide 3-
kinase (P13K) inhibitor [30]. NFAT pathway is helpful to cure the progressive tumors in the body, where drugs are designed with 
excessive Ca2+  signalling [31].  Phosphorylation of a tyrosine and threonine activates MAP kinase pathway which can suppress 
the growth of  colon tumors. Similarly  NF-αβ activation contributes to degrade various inflammatory diseases [32,33]. One can 
model these pathway differently  to study their function in curing diseases. Petri net modeling helps to know the system in a proper 
way as we can predicts the liveness , boundedness, finding the deadlock, and the reachable states of the system.   
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